Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fibrolamellar hepatocellular carcinoma × dostarlimab × 30 days × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 1 Pathologic Complete Response 1 Neoplasms 1 Hemangiosarcoma 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1

Interventions

poly ICLC 1 pembrolizumab 1 atezolizumab 1 Specimen Handling 1 Sorafenib 1 Nivolumab 1 Irinotecan 1 Ipilimumab 1 DT2216 1 Cyclophosphamide 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡